Quarterly Results: Alembic Pharmaceuticals Ltd.
Bhagyashree Vivarekar / 25 Jan 2017
The company's stock opened for trading at Rs 585 on the BSE and fell 0.79 per cent. It is currently trading around the Rs 580.75. The company reported PAT of Rs 86.55 crore, which represents a sequential QoQ decline of 27.45 per cent and a YoY decline of 67.8 per cent.
Alembic Pharmaceuticals Ltd. reported its results for the quarter ended December 31, 2016 during market hours today.
The total sales for Q3FY17 came in at Rs 777 crore, which represents a 11.64 per cent sequential decline and 16.52 per cent YoY decline.
The operating profit (EBIT) for the quarter amounted to Rs 124.3 crore and the EBIT margin stood at 16 per cent.
The company reported PAT of Rs 86.55 crore, which represents a sequential QoQ decline of 27.45 per cent and a YoY decline of 67.8 per cent.
The company's stock opened for trading at Rs 585 on the BSE and fell 0.79 per cent. It is currently trading around the Rs 580.75.
Alembic Pharmaceuticals Ltd is an India-based integrated pharmaceutical company. The company's business is divided into several segments, such as active pharmaceutical ingredients, bulk pharma chemicals, formulations, herbal nutraceuticals, veterinary and contract/ collaborated research services.
If you want to stay updated with the share market news today, keep a close watch on the indian stock market today with real time movements like sensex today live and overall stock market today trends. Investors tracking ipo allotment status, ipo news today, or the latest ipo india can also follow daily updates along with bse share price live data. Whether you are learning how to invest in stock market in india, preparing for a market crash today, or searching for the best stocks to buy in india, insights on top gainers today india, top losers today india, trending stocks india and long term stocks india help in making informed investment decisions.